A method for preparing 1-methyl-5-flupyrazole
By adopting a process route of chlorination followed by halogen exchange, the problems of poor regioselectivity and low yield in the preparation of 1-methyl-5-flupyrazole in the existing technology have been solved, realizing the preparation of high-purity, low-cost, and safe 1-methyl-5-flupyrazole, which is suitable for industrial application.
Patent Information
- Application Number
- CN202611504999.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-09-24
- Publication Date
- 2026-11-17
AI Technical Summary
Existing technologies for preparing 1-methyl-5-flupyrazole suffer from poor regioselectivity, low yield, poor safety, and high cost, making them unsuitable for industrial production.
A process route of chlorination followed by halogen exchange was adopted. 1-methyl-5-chloropyrazole was generated by reacting 1-methyl-5-pyrazole with phosphorus oxychloride. Then, 1-methyl-5-fluoropyrazole was prepared by reacting it with potassium fluoride in a high-boiling-point polar aprotic solvent.
It has achieved the preparation of high-purity (over 99%) products, significantly reduced the content of regioisomer impurities, and is highly safe, low in cost, and suitable for industrial production.
Smart Images

Figure CN123106537A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of pharmaceutical and chemical technology, and in particular to a method for preparing 1-methyl-5-fluopyrazole. Background Technology
[0002] 1-Methyl-5-fluopyrazole is an important fluorinated heterocyclic compound widely used as a pharmaceutical intermediate (such as the side chain of the antifungal drug fluconazole) and a pesticide intermediate. Particularly in the pharmaceutical field, the introduction of fluorine atoms can significantly alter the lipophilicity, metabolic stability, and bioavailability of the molecule; therefore, the preparation of this compound has significant application value.
[0003] Currently, there are two main existing process routes for preparing 1-methyl-5-flupyrazole: (1) Direct fluorination method Using 1-methyl-5-pyrazol as a raw material, nucleophilic substitution is performed directly using fluorinating agents diethylaminosulfur trifluoride (DAST) or sulfur tetrafluoride. This process has poor safety, high cost, and low selectivity. The raw material 1-methyl-5-pyrazol exhibits keto-enol tautomerism, which often results in the product containing regioisomers such as 1-methyl-3-fluoropyrazol, which are difficult to separate.
[0004] (2) Diazotization-fluorination method Using 1-methyl-5-aminopyrazole as a raw material, a diazonium salt is generated through a diazotization reaction, followed by the formation of diazonium fluoroborate in the presence of fluoroboric acid. Finally, the product is decomposed by heating to obtain the fluorinated product. This process is cumbersome, involves significant safety risks related to diazonium salts, and has a low overall yield.
[0005] Therefore, there is an urgent need to develop a method for preparing 1-methyl-5-flupyrazole that is regionally selective, has a high yield, low cost, is safe and controllable, and is suitable for industrial production. Summary of the Invention
[0006] The technical problem to be solved by the present invention is to provide a method for preparing 1-methyl-5-flupyrazole that has good regional selectivity, high yield, low cost, safety and controllability, and is suitable for industrial production.
[0007] The present invention solves the above-mentioned technical problems by adopting the following technical solutions: A method for preparing 1-methyl-5-flupyrazole includes the following steps: S1. Mix 1-methyl-5-pyrazolol with phosphorus oxychloride and carry out a chlorination reaction at 80~90℃; after the reaction is completed, distill under reduced pressure, and quench the residue with ice water, extract with dichloromethane, dry the organic phase and concentrate to obtain 1-methyl-5-chloropyrazol. S2. Dissolve the 1-methyl-5-chloropyrazole obtained in step S1 in a high-boiling-point polar aprotic solvent, add potassium fluoride, and carry out a halogen exchange reaction at 150~160℃. After the reaction is completed, cool the solution and pour it into ice water. Then extract with ethyl acetate or dichloromethane. Wash the organic phase with water, dry it, and then distill it under reduced pressure to obtain the target product 1-methyl-5-fluoropyrazole.
[0008] Its synthetic route is as follows: .
[0009] As one of the preferred embodiments of the present invention, in step S1, the molar ratio of 1-methyl-5-pyrazolol to phosphorus oxychloride is 1:(3.0~3.5).
[0010] As one of the preferred embodiments of the present invention, in step S1, the reaction time of the chlorination reaction is 6-8 hours.
[0011] As one of the preferred embodiments of the present invention, in step S2, the high-boiling-point polar aprotic solvent is at least one of N-methylpyrrolidone, sulfolane, and dimethyl sulfoxide.
[0012] As one of the preferred embodiments of the present invention, in step S2, the molar ratio of 1-methyl-5-chloropyrazole to potassium fluoride is 1:(2.4~3.2).
[0013] As one of the preferred embodiments of the present invention, in step S2, the reaction time of the halogen exchange reaction is 10-12 hours.
[0014] The advantages of this invention compared to the prior art are: (1) Good regioselectivity and high product purity: The present invention adopts an indirect synthesis strategy of chlorination followed by halogen exchange fluorination, which effectively avoids the problem of ketone-enol tautomerism in the raw material 1-methyl-5-pyrazol under direct fluorination conditions, resulting in regioisomers. It significantly reduces the content of difficult-to-separate impurities such as 1-methyl-3-fluoropyrazol, and the purity of the target product can reach more than 99%. (2) High safety and strong controllability of operation: This invention does not require the use of highly toxic and dangerous fluorination reagents such as diethylaminosulfur trifluoride (DAST) and sulfur tetrafluoride, nor does it involve diazotization reaction and diazonium salt intermediates with poor thermal stability. The reaction conditions are mild, with no risk of violent exothermic reaction or explosion, and the production operation is safe and controllable. (3) High reaction yield and low preparation cost: The total yield of the two-step reaction of this invention can reach more than 70%; the raw materials used, 1-methyl-5-pyrazolol, phosphorus oxychloride and potassium fluoride, are all readily available chemical raw materials with low prices, which greatly reduces the production cost compared with the existing technology; (4) The post-processing is simple and suitable for industrial scale-up production: The intermediates and products of this invention can be separated and purified by extraction and vacuum distillation, without the need for complex operations such as column chromatography. The process is simple, the production efficiency is high, and it is easy to realize large-scale industrial production. Attached Figure Description
[0015] Figure 1 This is a high-performance liquid chromatogram of the 1-methyl-5-flupyrazole product from Example 1. Detailed Implementation
[0016] The embodiments of the present invention are described in detail below. These embodiments are implemented based on the technical solution of the present invention, and provide detailed implementation methods and specific operating procedures. However, the scope of protection of the present invention is not limited to the following embodiments. Furthermore, the raw materials, reagents, equipment, and methods used in the present invention, unless otherwise specified, are all conventional raw materials, reagents, equipment, and methods in the art, and will not be described in detail further.
[0017] Example 1: Preparation of 1-methyl-5-flupyrazole:
[0018] Synthesis of S1, 1-methyl-5-chloropyrazole 150 mL of phosphorus oxychloride was added to 1-methyl-5-pyrazol (50.0 g, 0.51 mol), and the mixture was heated to 80 °C and stirred for 8 h (chlorination reaction). After the reaction was completed, excess phosphorus oxychloride was removed by vacuum distillation, the residue was quenched with ice water, extracted with dichloromethane, and the organic phase was dried over anhydrous sodium sulfate and concentrated to obtain 1-methyl-5-chloropyrazol (54 g, yield 91%) with a purity of 98.2%.
[0019] S2. Obtaining the target product The 1-methyl-5-chloropyrazole (40.0 g, 0.34 mol) obtained in step S1 was dissolved in 200 mL of N-methylpyrrolidone, and potassium fluoride (60.0 g, 1.03 mol) was added. The mixture was heated to 150 °C and stirred for 12 hours (halogen exchange fluorination reaction). After the reaction was completed, the mixture was cooled and poured into 500 mL of ice water. The mixture was extracted three times with ethyl acetate. The organic phases were combined, washed with water, dried over anhydrous sodium sulfate, and the fraction was collected by vacuum distillation to obtain the target product 1-methyl-5-fluoropyrazole (27.5 g, yield 80%).
[0020] The purity of the product was determined to be 99.1% by high-performance liquid chromatography (HPLC, 226 nm). Figure 1 ).
[0021] 1H-NMR (400MH, CDCl3): δ=7.38 (dd,1H), 5.82 (t,1H), 3.81 (s,3H).
[0022] MS(ESI): 101.1 [M+H] + .
[0023] Characterized by high performance liquid chromatography, nuclear magnetic resonance hydrogen spectroscopy and mass spectrometry, the structure of the obtained product is completely consistent with the target compound 1-methyl-5-flupyrazole, and the content of regioisomer impurities such as 1-methyl-3-flupyrazole in the product is extremely low.
[0024] Example 2, Preparation of 1-methyl-5-flupyrazole:
[0025] Synthesis of S1, 1-methyl-5-chloropyrazole 225 mL of phosphorus oxychloride was added to 1-methyl-5-pyrazol (75.0 g, 0.76 mol), and the mixture was heated to 85 °C and stirred for 7 h (chlorination reaction). After the reaction was completed, excess phosphorus oxychloride was removed by vacuum distillation, the residue was quenched with ice water, extracted with dichloromethane, and the organic phase was dried over anhydrous sodium sulfate and concentrated to obtain 1-methyl-5-chloropyrazol (82 g, yield 92%) with a purity of 98.5%.
[0026] S2. Obtaining the target product The 1-methyl-5-chloropyrazole (60.0 g, 0.515 mol) obtained in step S1 was dissolved in 200 mL of dimethyl sulfoxide, and potassium fluoride (88.0 g, 1.514 mol) was added. The mixture was heated to 155 °C and stirred for 11 hours (halogen exchange fluorination reaction). After the reaction was completed, the mixture was cooled and poured into 500 mL of ice water. It was extracted three times with dichloromethane. The organic phases were combined, washed with water, dried over anhydrous sodium sulfate, and the fraction was collected by vacuum distillation to obtain the target product 1-methyl-5-fluoropyrazole (40.8 g, yield 79%). The purity of the product was 99.2% as determined by high performance liquid chromatography (HPLC, 226 nm).
[0027] Example 3: Preparation of 1-methyl-5-flupyrazole:
[0028] Synthesis of S1, 1-methyl-5-chloropyrazole 300 mL of phosphorus oxychloride was added to 1-methyl-5-pyrazol (100.0 g, 1.02 mol), and the mixture was heated to 90 °C and stirred for 6 h (chlorination reaction). After the reaction was completed, excess phosphorus oxychloride was removed by vacuum distillation, the residue was quenched with ice water, extracted with dichloromethane, and the organic phase was dried over anhydrous sodium sulfate and concentrated to obtain 1-methyl-5-chloropyrazol (107 g, yield 90%) with a purity of 97.8%.
[0029] S2. Obtaining the target product The 1-methyl-5-chloropyrazole (100.0 g, 0.86 mol) obtained in step S1 was dissolved in 200 mL of sulfolane, and potassium fluoride (130 g, 2.24 mol) was added. The mixture was heated to 160 °C and stirred for 10 hours (halogen exchange fluorination reaction). After the reaction was completed, the mixture was cooled and poured into 500 mL of ice water. It was extracted three times with ethyl acetate. The organic phases were combined, washed with water, dried over anhydrous sodium sulfate, and the fraction was collected by vacuum distillation to obtain the target product 1-methyl-5-fluoropyrazole (70.6 g, yield 82%). The purity of the product was 99.3% as determined by high performance liquid chromatography (HPLC, 226 nm).
[0030] In summary, this invention uses a process of chlorination followed by halogen exchange fluorination to prepare 1-methyl-5-flupyrazole, which can obtain a high-purity (over 99%) target product with extremely low content of regiomeric impurities such as 1-methyl-3-flupyrazole. The total yield of the two steps can reach over 70%, showing good prospects for industrial application.
[0031] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, and improvements made within the spirit and principles of the present invention should be included within the protection scope of the present invention.
Claims
1. A method for preparing 1-methyl-5-fluopyrazole, characterized in that, Includes the following steps: S1. Mix 1-methyl-5-pyrazolol with phosphorus oxychloride and carry out a chlorination reaction at 80~90℃; after the reaction is completed, distill under reduced pressure, and quench the residue with ice water, extract with dichloromethane, dry the organic phase and concentrate to obtain 1-methyl-5-chloropyrazol. S2. Dissolve the 1-methyl-5-chloropyrazole obtained in step S1 in a high-boiling-point polar aprotic solvent, add potassium fluoride, and carry out a halogen exchange reaction at 150~160℃. After the reaction is completed, cool the solution and pour it into ice water. Then extract with ethyl acetate or dichloromethane. Wash the organic phase with water, dry it, and then distill it under reduced pressure to obtain the target product 1-methyl-5-fluoropyrazole.
2. The preparation method according to claim 1, characterized in that, In step S1, the molar ratio of 1-methyl-5-pyrazolol to phosphorus oxychloride is 1:(3.0~3.5).
3. The preparation method according to claim 1, characterized in that, In step S1, the chlorination reaction takes 6-8 hours.
4. The preparation method according to claim 1, characterized in that, In step S2, the high-boiling-point polar aprotic solvent is at least one of N-methylpyrrolidone, sulfolane, and dimethyl sulfoxide.
5. The preparation method according to claim 1, characterized in that, In step S2, the molar ratio of 1-methyl-5-chloropyrazole to potassium fluoride is 1:(2.4~3.2).
6. The preparation method according to claim 1, characterized in that, In step S2, the halogen exchange reaction takes 10-12 hours.
